Abstract
Background to the audit: There is increasing use of neoadjuvant radiotherapy (RT) prior to curative surgery in soft tissue sarcoma. This involves a lower dose, smaller margins and can improve patients’ functional outcomes when compared to postoperative RT, but at the expense of an increased risk of acute wound complications.[1]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
